1. Home
  2. RGEN vs LPX Comparison

RGEN vs LPX Comparison

Compare RGEN & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • LPX
  • Stock Information
  • Founded
  • RGEN 1981
  • LPX 1973
  • Country
  • RGEN United States
  • LPX United States
  • Employees
  • RGEN N/A
  • LPX N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • LPX Forest Products
  • Sector
  • RGEN Health Care
  • LPX Basic Materials
  • Exchange
  • RGEN Nasdaq
  • LPX Nasdaq
  • Market Cap
  • RGEN 6.5B
  • LPX 6.3B
  • IPO Year
  • RGEN N/A
  • LPX N/A
  • Fundamental
  • Price
  • RGEN $145.83
  • LPX $89.10
  • Analyst Decision
  • RGEN Buy
  • LPX Buy
  • Analyst Count
  • RGEN 11
  • LPX 8
  • Target Price
  • RGEN $167.90
  • LPX $112.13
  • AVG Volume (30 Days)
  • RGEN 929.7K
  • LPX 787.4K
  • Earning Date
  • RGEN 11-11-2025
  • LPX 11-04-2025
  • Dividend Yield
  • RGEN N/A
  • LPX 1.25%
  • EPS Growth
  • RGEN N/A
  • LPX N/A
  • EPS
  • RGEN N/A
  • LPX 4.23
  • Revenue
  • RGEN $673,956,000.00
  • LPX $2,880,000,000.00
  • Revenue This Year
  • RGEN $16.77
  • LPX N/A
  • Revenue Next Year
  • RGEN $13.79
  • LPX $7.88
  • P/E Ratio
  • RGEN N/A
  • LPX $21.20
  • Revenue Growth
  • RGEN 8.73
  • LPX N/A
  • 52 Week Low
  • RGEN $102.97
  • LPX $78.82
  • 52 Week High
  • RGEN $182.52
  • LPX $122.87
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 68.33
  • LPX 47.00
  • Support Level
  • RGEN $121.25
  • LPX $87.95
  • Resistance Level
  • RGEN $125.90
  • LPX $90.90
  • Average True Range (ATR)
  • RGEN 5.31
  • LPX 2.40
  • MACD
  • RGEN 2.79
  • LPX 0.36
  • Stochastic Oscillator
  • RGEN 84.15
  • LPX 68.52

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About LPX Louisiana-Pacific Corporation

Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.

Share on Social Networks: